# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.axios.com/2025/10/16/weightwatchers-glp1-menopause-program
WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed wei...
Morgan Stanley analyst Lauren Schenk maintains WW International (NASDAQ:WW) with a Equal-Weight and lowers the price target ...
WW International Q2 FY2025 earnings call transcript
WW International, Inc. (NASDAQ: WW) stock surged on strong financial results, with Clinical subscription revenues rising and de...
WW International (NASDAQ:WW) sees FY2025 sales of $685.000 million-$700.000 million vs $737.722 million analyst estimate.